News Fine pharma for price gouging, says Clinton Hillary Clinton wants to fine companies for gouging prices of generics.
News Clinton attacks Mylan over drug pricing Presidential hopeful criticises "outrageous" EpiPen price increase.
News German pricing changes to hit blockbuster revenues But pharma will be able to negotiate confidential prices.
News Biosimilars don't need big market share to bring savings - I... Competition can also drive down price of entire drug class.
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
